It’s great to hear that Moderna is entering late-stage vaccine trials for Covid-19. We certainly hope they will be able to provide a vaccine soon. With about 200 vaccines being developed, many undergoing clinical trials, we certainly hope one will emerge as a viable product for the good of mankind.
Apparently, Moderna will be pricing it’s vaccine higher than what it’s peers will offer. Is this the right thing to do at a time like this? Their stock price would already have risen significantly with news of its vaccine. Would their pricing strategy backfire on them?
